Elagolix Sodium
Elagolix is a selective, orally active GnRH receptor antagonist (Ki = 0.9 nM) that inhibits GnRH-induced signaling (IC50 = 1.5 nM). It suppresses luteinizing hormone production in vivo and has been used in formulations for treating endometriosis-related pain. Elagolix is highly selective, with minimal activity against CYP3A4 and other receptors. Reagent grade, for research use only.

-
Catalog:
BP-43648
-
Name:
Elagolix Sodium
-
Formula:
C32H29F5N3NaO5
-
MW:
653.6
-
CAS:
832720-36-2
-
Purity:
-
Ships Within:
24 Hours
-
Storage Condition:
-20°C
-
Shipping:
Ambient Temperature
-
NMR:
View
-
SDS:
Inquire about MSDS